-

06:47:04 PM

DRIO Stock News

DRIO - DarioHealth Corp

09/22/22 8:00 AM

Nasdaq : DRIO

clinical triallow float

DarioHealth Publishes New Clinical Research Linking the Use of its Biofeedback Device to Reduced Back Pain

DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today new research examining the link between the use of Dario's

RHEA-AI

very positive

09/20/22 8:00 AM

Nasdaq : DRIO

low float

DarioHealth Announces Two New Employer Contracts

DarioHealth Corp. (NASDAQ: DRIO) (the "Company" or "Dario"), a leader in the global digital therapeutics (DTx) market, announced today two

RHEA-AI

very positive

08/15/22 6:30 AM

Nasdaq : DRIO

low float

DarioHealth Reports Second Quarter 2022 Financial and Operating Results

Q2 revenue of 6.2 million, a 17.5% increase from the $5.3 million of the second quarter of 2021. Six-month year-to-date revenue totaled $14.2 million, a 60.8% increase over the first six months of 2021 $55 million in total commercial contract value reflecting continued strong momentum across

RHEA-AI

neutral

08/12/22 8:00 AM

Nasdaq : DRIO

low float

DarioHealth Presents New Research Demonstrating the Ability to Support People in Rural Areas and Deliver Lasting Health Improvements

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx)

RHEA-AI

neutral

08/11/22 8:00 AM

Nasdaq : DRIO

low float

DarioHealth Selected by National Health Plan to Enhance Mental Health and Well-Being for Members

DarioHealth Corp. ("Dario", "DarioHealth" or the "Company") (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market,

RHEA-AI

very positive

08/10/22 8:00 AM

Nasdaq : DRIO

conferenceslow float

DarioHealth to Report Second Quarter 2022 Results on Monday, August 15

DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the second quarter ended June 30, 2022, on

RHEA-AI

neutral

08/04/22 8:00 AM

Nasdaq : DRIO

low float

DarioHealth Presents New Research Demonstrating the Impact of a Digital Solution on Depression and Anxiety at the American Psychological Association Annual Convention

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced

RHEA-AI

neutral

07/21/22 8:00 AM

Nasdaq : DRIO

low float

DarioHealth Demonstrates Continued Growth in Multi-Chronic Contracts with Latest Addition of a National Employer for the Full Solution Suite

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced a new contract to deliver its full suite of

RHEA-AI

neutral

06/21/22 8:17 AM

Nasdaq : DRIO

low float

DarioHealth Announces New Contract with a National Employer

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced a new contract to deliver its digital behavioral health solution for a leading provider of

RHEA-AI

neutral

06/15/22 8:48 PM

Nasdaq : DRIO

low float

Solera Health Adds DarioHealth to Its Cardiometabolic Network to Offer Hypertension Management Solutions

Solera Health, the premier platform for connecting people seamlessly and easily to proven, personalized health

RHEA-AI

positive

1 2 3 4 5 6 7 8 9 10 Next

DRIO Data

IndustrySurgical and Medical Instrument Manufacturing
Websitewww.mydario.com
Security nameDarioHealth Corp
Issue typecs
SectorManufacturing
Sic code3841
Employees133
Tags
- Health Technology
- Medical Specialties
- Manufacturing
- Surgical and Medical Instrument Manufacturing

About DarioHealth Corp

DarioHealth Corp. is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, the Company empowers individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Its cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario™mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease.